CJC-1295
Research compoundaka CJC1295, with/without DAC
Long-acting GHRH analog. The usual partner for ipamorelin.
Mechanism
A GHRH analog that tells the pituitary to put out GH. The DAC version grabs onto albumin so it sticks around for days, keeping GH and IGF-1 elevated. Pair it with a GHRP like ipamorelin and you hit the GH pulse from both directions.
Regulatory & Safety Status
Not an approved drug, and human data is thin. Research chemical only.
Research
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
CJC-1295 GHRH analog research
Latest CJC-1295 research